CorMedix, Inc. announced that Alan W. Dunton, M.D. has been appointed unanimously to the Company's Board of Directors. Dr. Dunton becomes the sixth member of the Company's Board, filling a vacant seat previously occupied by Gary Gelbfish, M.D., who resigned in January 2019. Dr. Dunton has devoted his 35-year career to the discovery and development of new drug products. Most recently, he was Senior Vice President of Research and Development at Purdue Pharmaceuticals L.P., based in Stamford, CT. During his career, Dr. Dunton has built a successful consulting company, Danerius LLC. He was also chief executive officer of two biotech companies, and was President and Managing Director of the Janssen Research Foundation, the R&D and regulatory arm of the pharmaceutical division of Johnson &Johnson.